← Home
/
Summit Therapeutics Inc. (SMMT)
Stock Analysis
Summit Therapeutics Inc. (SMMT)
SMMT
SMMT · Market data
14.57
+1.75%
Updated: 2026-06-30 15:40 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Vulnerable
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
—
↗
Break Above
Confirmation improves above resistance.
15.98
🎯
Next Objective
Pattern-derived target if setup continues.
11.68
×
Thesis Break
Scenario weakens below invalidation.
Below —
What's Driving SMMT?
📈 Technical recovery is improving
Momentum is Neutral. Watch 15.98 for confirmation and — for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-06-29
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$11.1B
Company size
EV
$11.0B
Debt-adjusted value
EV/EBIT
-48.7
Not meaningful
P/FCF
-28.9
Not meaningful
FCF Yield
-3.46%
Cash return
Source: SEC TTM data via WOI valuation cache
Not financial advice
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
💵 Revenue
0.00
≈ Insufficient
📈 Net Income
-189.42M
≈ Insufficient
🧮 EPS (Basic)
-0.24
≈ Insufficient
Note: This is an algorithmic technical snapshot, not financial advice.